🔗 Share this article

The Nobel Prize in Physiology or Medicine was awarded for transformative findings that clarify how the immune system targets dangerous infections while sparing the healthy tissues.

A trio of renowned researchers—Japan's Prof. Sakaguchi and US experts Mary Brunkow and Fred Ramsdell—received this honor.

Their research identified unique "sentinels" within the immune system that remove malfunctioning immune cells that could attacking the body.

The discoveries are now paving the way for innovative treatments for autoimmune diseases and cancer.

These laureates will share a prize fund valued at 11m SEK.

Crucial Discoveries

"Their work has been essential for comprehending how the body's defenses operates and the reason we don't all develop severe autoimmune diseases," stated the chair of the Nobel Committee.

The trio's research explain a fundamental mystery: How does the defense system defend us from countless invaders while keeping our healthy cells unharmed?

The immune system employs white blood cells that scan for signs of infection, including pathogens and germs it has never encountered.

These defenders utilize sensors—known as recognition units—that are produced randomly in a vast number of combinations.

This provides the immune system the capacity to combat a wide array of threats, but the unpredictability of the mechanism unavoidably produces immune cells that can target the body.

Protectors of the Immune System

Researchers earlier knew that some of these problematic defense cells were eliminated in the immune organ—where white blood cells develop.

This year's Nobel Prize honors the discovery of T-reg cells—known as the body's "peacekeepers"—which patrol the system to neutralize other defenders that assault the body's own tissues.

It is known that this mechanism malfunctions in self-attack conditions such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

The prize committee stated, "The discoveries have established a new field of investigation and spurred the development of innovative treatments, for instance for cancer and autoimmune diseases."

In malignancies, T-regs block the body from attacking the tumor, so studies are aimed at lowering their quantity.

In autoimmune diseases, trials are testing boosting T-reg cells so the body is no longer under attack. A similar approach could also be useful in reducing the chances of transplanted organ failure.

Innovative Experiments

Prof Sakaguchi, from Osaka University, conducted experiments on rodents that had their immune gland removed, leading to self-attack conditions.

The researcher showed that injecting defense cells from other animals could prevent the disease—implying there was a system for blocking defenders from harming the host.

Mary Brunkow, from the Institute for Systems Biology in a US city, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in a California city, were investigating an inherited autoimmune disease in rodents and people that resulted in the identification of a gene vital for the way T-regs operate.

"The pioneering research has revealed how the immune system is controlled by regulatory T cells, stopping it from accidentally attacking the healthy cells," said a prominent biological science specialist.

"This work is a striking example of how basic biological study can have far-reaching implications for human health."